Cardinal Health, Inc. $CAH Shares Sold by Blue Trust Inc.

Blue Trust Inc. trimmed its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 7.9% in the 2nd quarter, HoldingsChannel reports. The firm owned 2,861 shares of the company’s stock after selling 247 shares during the period. Blue Trust Inc.’s holdings in Cardinal Health were worth $481,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Greykasell Wealth Strategies Inc. acquired a new position in Cardinal Health during the 1st quarter worth $26,000. Jones Financial Companies Lllp grew its stake in Cardinal Health by 198.3% during the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after purchasing an additional 14,034 shares in the last quarter. GW&K Investment Management LLC grew its stake in Cardinal Health by 113.4% during the 1st quarter. GW&K Investment Management LLC now owns 271 shares of the company’s stock worth $37,000 after purchasing an additional 144 shares in the last quarter. Garde Capital Inc. acquired a new position in Cardinal Health during the 1st quarter worth $52,000. Finally, Zions Bancorporation National Association UT acquired a new position in Cardinal Health during the 1st quarter worth $52,000. 87.17% of the stock is owned by institutional investors and hedge funds.

Cardinal Health Stock Down 0.2%

Shares of NYSE CAH opened at $156.86 on Monday. The stock has a market cap of $37.27 billion, a PE ratio of 24.32, a price-to-earnings-growth ratio of 1.33 and a beta of 0.71. Cardinal Health, Inc. has a 52-week low of $106.98 and a 52-week high of $168.44. The business has a 50-day moving average price of $152.09 and a 200 day moving average price of $151.31.

Cardinal Health (NYSE:CAH) last announced its earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.03 by $0.05. The firm had revenue of $60.16 billion during the quarter, compared to analysts’ expectations of $60.91 billion. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The business’s revenue was up .5% on a year-over-year basis. During the same period in the prior year, the firm earned $1.84 EPS. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. Sell-side analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be given a $0.5107 dividend. The ex-dividend date of this dividend is Wednesday, October 1st. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.3%. Cardinal Health’s dividend payout ratio is 31.63%.

Analyst Ratings Changes

Several research analysts have recently issued reports on the company. Wall Street Zen cut Cardinal Health from a “strong-buy” rating to a “buy” rating in a research report on Saturday, August 2nd. Jefferies Financial Group set a $150.00 price objective on Cardinal Health in a research report on Tuesday, August 12th. Leerink Partners upped their price objective on Cardinal Health from $186.00 to $187.00 and gave the stock an “outperform” rating in a research report on Monday, October 6th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of Cardinal Health in a research report on Wednesday, October 8th. Finally, Evercore ISI lowered their price objective on Cardinal Health from $200.00 to $190.00 and set an “outperform” rating for the company in a research report on Wednesday, August 13th. Twelve research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $166.00.

Insider Transactions at Cardinal Health

In other Cardinal Health news, CEO Stephen M. Mason sold 41,575 shares of the company’s stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $6,187,191.50. Following the completion of the sale, the chief executive officer directly owned 26,085 shares of the company’s stock, valued at $3,881,969.70. This represents a 61.45% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Ola M. Snow sold 28,151 shares of the company’s stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $148.94, for a total value of $4,192,809.94. Following the sale, the insider directly owned 15,431 shares of the company’s stock, valued at approximately $2,298,293.14. This represents a 64.59% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 271,676 shares of company stock worth $40,489,525. Insiders own 0.12% of the company’s stock.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.